Stage 2: Silent
出自KMU Wiki
(修訂版本間差異)
在2018年3月13日 (二) 17:33所做的修訂版本 (編輯) Guhjy (對話 | 貢獻) ←上一個 |
當前修訂版本 (2018年3月13日 (二) 17:33) (編輯) (撤銷) Guhjy (對話 | 貢獻) |
||
第6行: | 第6行: | ||
***Loss of charge selectivity for proteins | ***Loss of charge selectivity for proteins | ||
****Proteinuria or albuminuria | ****Proteinuria or albuminuria | ||
- | *Mesangial expansion or sclerosis | + | **Mesangial expansion or sclerosis |
*Pathogenesis | *Pathogenesis | ||
**Glomerular hypertension | **Glomerular hypertension |
當前修訂版本
2-3rd year 40% progress to stage 3
- Pathology
- Thick GBM
- Heparan sulfate lost
- Loss of charge selectivity for proteins
- Proteinuria or albuminuria
- Loss of charge selectivity for proteins
- Mesangial expansion or sclerosis
- Pathogenesis
- Glomerular hypertension
- Proteinuria
- Advanced glycosylation end products ↑
- Growth hormone ↑
- IGF-I ↑
- Angiotensin II ↑
- Connective tissues growth factor ↑
- Transforming growth factor-β
- Hyperlipidemia